where to get glp-1 drugs Costs Explained: Managing Coverage Challenges American drugmakers pushed GLP1 therapies

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes

doi: 10.1038/s41421-024-00700-0

The rapid weight loss that Retatrutide produces can lead to muscle loss if protein intake falls too low

6X18: Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, enel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D

Cardiovascular Disease and Risk Management: standards of Medical Care in Diabetes-2018

This does not necessarily mean that these medications do not have a place in the management of the condition, however